Mitsuhiro Ibe
President chez ZERIA PHARMACEUTICAL CO., LTD.
Fortune : 1 M $ au 29/02/2024
Profil
Currently, Mitsuhiro Ibe occupies the position of President, COO & Representative Director at Zeria Pharmaceutical Co., Ltd.
He is also on the board of Tillotts Pharma AG.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
31/03/2023 | 77 000 ( 0,14% ) | 1 M $ | 29/02/2024 |
Postes actifs de Mitsuhiro Ibe
Sociétés | Poste | Début |
---|---|---|
ZERIA PHARMACEUTICAL CO., LTD. | President | 01/06/2014 |
Tillotts Pharma AG
Tillotts Pharma AG Pharmaceuticals: MajorHealth Technology Tillotts Pharma AG manufactures pharmaceuticals for treatment of gastrointestinal diseases. The firm specializes in the therapy of the lower gastrointestinal tract. It offers Asacol, Entocort, Colpermin, Tillhepo and VistaPrep. The company was founded in 1986 and is headquartered in Ziefen, Switzerland. | Director/Board Member | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ZERIA PHARMACEUTICAL CO., LTD. | Health Technology |
Entreprise privées | 1 |
---|---|
Tillotts Pharma AG
Tillotts Pharma AG Pharmaceuticals: MajorHealth Technology Tillotts Pharma AG manufactures pharmaceuticals for treatment of gastrointestinal diseases. The firm specializes in the therapy of the lower gastrointestinal tract. It offers Asacol, Entocort, Colpermin, Tillhepo and VistaPrep. The company was founded in 1986 and is headquartered in Ziefen, Switzerland. | Health Technology |